This article has Open Peer Review reports available.
Cardiac tamponade and paroxysmal third-degree atrioventricular block revealing a primary cardiac non-Hodgkin large B-cell lymphoma of the right ventricle: a case report
© Frikha et al; licensee BioMed Central Ltd. 2011
Received: 1 March 2011
Accepted: 5 September 2011
Published: 5 September 2011
Primary cardiac lymphoma is rare.
We report the case of a 64-year-old non-immunodeficient Caucasian man, with cardiac tamponade and paroxysmal third-degree atrioventricular block. Echocardiography revealed the presence of a large pericardial effusion with signs of tamponade and a right ventricular mass was suspected. Scanner investigations clarified the sites, extension and anatomic details of myocardial and pericardial infiltration. Surgical resection was performed due to the rapid impairment of his cardiac function. Analysis of the pericardial fluid and histology confirmed the diagnosis of non-Hodgkin large B-cell lymphoma. He was treated with chemotherapy.
The prognosis remains poor for this type of tumor due to delays in diagnosis and the importance of the site of disease.
Primary cardiac tumors are rare. Cardiac lymphoma is the rarest primary cardiac tumor and it is usually fatal. The prognosis is poor because of diagnostic delay and the importance of the site of disease. It often begins with a pericardial effusion. Its treatment is based on chemotherapy.
Due to the rapid impairment of his cardiac function and the life-threatening hemodynamic instability, an echocardiography was performed which showed an obstruction of the right ventricle inflow.
He underwent an emergency thoracotomy. The purpose of this surgery was not to remove the entire tumor. It was limited to freeing the tricuspid valve and the intra-right ventricle obstruction. Surgical resection of the mass was difficult and incomplete. The tumor had infiltrated his right atrium, the atrioventricular septum and the proximal side of the right ventricle. Surgical removal was laborious but without complications.
Chemotherapy with the R-CHOP (Rituximab, Cytoxan, Hydroxydaunorubicin (Adriamycin), Oncovin (Vincristine), Prednisone/Prednisolone) regimen began immediately after resection.
Primary cardiac tumors are extremely rare in immunocompetent persons. They are more frequent in patients with acquired immunodeficiency syndrome (AIDS) or in transplant recipients. This was not the case in our patient. Approximately 25% of primary cardiac tumors are malignant. Cardiac tumors are classified according to their location and the degree of intra-cavitary obstruction. It is interesting to separate primary cardiac lymphoma in which cardiac events are the first indications, from secondary locations in which general events are predominant and the discovery of the cardiac involvement is often fortuitous .
Primary cardiac lymphoma is an extranodal non-Hodgkin lymphoma exclusively located in the heart and/or pericardium . It represents 1.3% of primary cardiac tumors (PCL) and less than 1% of all lymphomas [2–4]. The right atrium and right ventricle are the two most frequently involved sites with two-thirds of cases involving the right atrium [2–5].
Clinical presentations associated with primary cardiac lymphoma are heterogeneous. They are generally related to the site of involvement in the heart which makes early diagnosis difficult. In their series, Fuzellier et al. reported right-sided heart failure, dyspnea, tamponade and arrhythmias as the most frequent manifestations . Cardiac tamponade is a frequent mode of presentation. The association of a tamponade with an alteration of the general state or the general signs leads directly to a neoplasia disease [2–6]. Congestive heart failure is explained by myocardial involvement. The disorders of conduction are the consequence of the invasion of the inter-atrial septum likely with an extension to the nodal tissue. The mechanism of cardiac arrhythmia could be the infiltration of the roof of the side wall of the right atrium by the tumor tissue .
TTE visualizes the pericardial effusions easily. It also allows an estimation of its tolerance and reveals the presence of any intracardiac mass. TEE is considered an initial imaging method when an intra-cardiac mass is doubtful [8, 9]. ' It is better for identifying tumoral masses, allowing suspicion for an infiltrated cardiac tumoral mass to be a primary cardiac lymphoma' . The sensitivity of TEE for the detection of primary cardiac lymphoma approaches 100% in some series in specialized units that have experience with this kind of laboratory investigation . It is also a good follow-up examination allowing the verification of the regression of the tumor after chemotherapy in a few centers . TEE is excellent at visualizing tumors in the atria, but much less so for anterior masses (for example, near the right ventricular apex), where TTE is superior. In our department, we are experienced in diagnosing cardiac tumors and monitoring their regression by TTE. Computed tomography allows the delineation of the cardiac mass and the specification of its connections with the cardiac structures as well as the extent of the disease. An MRI becomes the examination reference for the diagnosis of cardiac tumors. It offers superior anatomic details of myocardial and pericardial infiltration. This examination can also serve as a reference for the follow-up of patients undergoing chemotherapy . However, fast moving tumors (such as some myxomas) will adversely affect the quality of the MRI image. In our patient who had an auriculoventricular block of the third degree in the electrocardiogram, echocardiography followed by computed tomography can help in arriving at a hypothesis to explain the origin of the conduction disorder. It is probable that the tumor in this case report invaded the inter-atrial septum and the atrioventricular node. We do not have any explanation for why it was paroxysmal. It is probable that the inflammation process around the tumor is the cause. Cytological analysis of the pericardial liquid does not always permit a diagnosis because the effusion can be reactive . The cytology results in the pericardial fluid are often nonspecific. It demonstrates atypical lymphoid cells . Most cases require biopsy or surgical excision for diagnosis . In the presence of a right-sided cardiac mass, an aggressive approach to obtain a rapid histological diagnosis is important. Less invasive procedures, such as TEE guided biopsy, endomyocardial transvenous biopsy, mediastinoscopy and thoracoscopic pericardial window have been performed with success .
The treatment of primary cardiac lymphoma is not clearly codified. It differs according to the clinical team. Surgical treatment is discouraging because surgical resection of primary cardiac lymphoma is often difficult and incomplete. It is reserved for patients with life-threatening hemodynamic compromise caused by mechanical complications (as was the case with our patient) or tamponade . Early systemic treatment appears to be the only chance for cure.
Chemotherapy remains the preferred initial treatment. It should be guided by the immunohistological characteristics of the lymphoma and its extension to other organs. At the end of the treatment, we can expect a reduction of any rhythm disorders due to regression of the tumor mass .
Primary cardiac lymphoma is rare. The presence of a right cardiac mass raises the possibility of primary cardiac lymphoma. Echocardiography is the preferred procedure for diagnosis and follow-up. In addition, it allows an estimation of the hemodynamic state. Rapid histological diagnosis is important because systemic therapy can influence the prognosis in the presence of a primary cardiac lymphoma .
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We thank Pr Mourad Hentati for his collaboration to elaborate this observation and for the care that he provided for the patient.
- Mikdame M, Ennebi K, Bahrouch L, Benyass A, Dreyfus F, Touloune F: Localisations cardiaques du lymphome non hodgkinien: à propos de quatre cas. Rev Med Interne. 2003, 24: 459-463. 10.1016/S0248-8663(03)00144-9.View ArticlePubMedGoogle Scholar
- Fuzellier JF, Saade YA, Torossian PF, Baehrel B: Primary cardiac lymphoma: Diagnosis and treatment. Arch Mal Coeur Vaiss. 2005, 98: 875-880.PubMedGoogle Scholar
- Sutcliffe SB, Gospodarowicz MK: Primary extranodal lymphomas. The Lymphomas. Edited by: Canellos GP, Lister TA, Sklar JL. 1998, Philadelphia: WB Saunders Company, 449-479.Google Scholar
- Quigley MM, Schwartzman E, Boswell PD, Christensen RL, Gleason LA, Sharpe RW, D'Amato TA: A unique atrial primary cardiac lymphoma mimicking myxoma presenting with embolic stroke: A case report. Blood. 2003, 101: 4708-4710. 10.1182/blood-2002-08-2550.View ArticlePubMedGoogle Scholar
- Ceresoli GL, Ferreri AJM, Bucci E, Ripa C, Ponzoni M, Villa E: Primary cardiac lymphoma in immunocompetent patients - diagnostic and therapeutic management. Cancer. 1997, 80: 1497-1506. 10.1002/(SICI)1097-0142(19971015)80:8<1497::AID-CNCR18>3.0.CO;2-0.View ArticlePubMedGoogle Scholar
- Mioulet D, Bræm L, Heno P, Paule P, Peloni JM, Bonnet D, Fourcade L: Flutter atrial révélateur de l'extension cardiaque d'un lymphome malin non hodgkinien. Ann Cardiol Angeiol. 2008, 10: 1016-1020.Google Scholar
- Donal E, Coisne Corbi P, Chritæns L, Menet E, Allal J, Barraine R: Cardiac lymphoma disclosed by tamponade and complete atrioventicular block: apropos of a surgically treated case. Heart and lymphoma. Ann Cardiol Angeiol. 1997, 46: 667-670.Google Scholar
- Moore JA, DeRan BP, Minor R, Arthur J, Fraker TD: Transesophageal echocardiographic evaluation of intracardiac lymphoma. Am Heart J. 1992, 124: 514-516. 10.1016/0002-8703(92)90623-4.View ArticlePubMedGoogle Scholar
- Mugge A, Daniel WG, Haverich A, Lichtlen PR: Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation. 1991, 83: 70-78.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.